Gilead gets Sovaldi patent approval in India despite opposition
10-05-2016
MSF urges Indian Patent Office to reject Gilead Sovaldi patent
02-03-2016
pio3 / Shutterstock.com
Activist organisation Médecins Sans Frontières (MSF) has challenged Pfizer’s patent application covering the pneumococcal conjugate vaccine on the grounds that it is obvious.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Médecins Sans Frontières; Pfizer; Indian Patent Office; European Patent Office;
